Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis

doi:10.4254/wjh.v4.i1.11

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3904)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

319

HTML

3194

Figures (1-2)

218

Tables (1-5)

173

Sum=3904

Jan 27, 2012 (publication date) through Sep 26, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Hepatol. Jan 27, 2012; 4(1): 11-17
Published online Jan 27, 2012. doi: 10.4254/wjh.v4.i1.11

Full Size Figure Download Figure

Figure 1 The glycated albumin/glycated hemoglobin ratio in relation to the METAVIR fibrosis score in patients with hepatitis C virus-related chronic liver disease. The glycated albumin (GA)/glycated hemoglobin (HbA1c) ratio increased as the fibrosis progressed. There was a significant difference between the F0-F1 vs F4, F2 vs F4, and F3 vs F4 groups.

Citation: Aizawa N, Enomoto H, Imanishi H, Saito M, Iwata Y, Tanaka H, Ikeda N, Sakai Y, Takashima T, Iwai T, Moriwaki EI, Shimomura S, Iijima H, Nakamura H, Nishiguchi S. Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis. World J Hepatol 2012; 4(1): 11-17
URL: https://www.wjgnet.com/1948-5182/full/v4/i1/11.htm
DOI: https://dx.doi.org/10.4254/wjh.v4.i1.11